Of the evaluated 100 cases, membranous Her2 expression was scored as 3 + in 2 cases (2%), 2 + in 10 cases (10%), 1 + in 12 cases (12%), and 0 in 76 cases (76%), according to ASCO/CAP guidelines of breast cancer, Fig. (2 A-D), figures were taken using Olympus EP50 camera, Japan. This evidence concerns the gene ERBB2 and breast carcinoma.